Optiray 300 636 mg/mL

Optiray 300 636 mg/mL is a radiopaque contrast agent used for diagnostic imaging procedures. This injection, containing ioversol, aids in enhancing visibility during X-rays and CT scans. Ideal for intra-arterial and intravenous administration, it supports clear imaging for better diagnostic outcomes.

Optiray 300 636 mg/mL is primarily used as a contrast medium to improve the visibility of internal structures during imaging procedures. It is commonly administered intravenously or intra-arterially to enhance the clarity of X-rays, CT scans, and other diagnostic imaging techniques. This helps healthcare professionals to better visualize blood vessels, organs, and tissues, aiding in the diagnosis of various conditions.

When administered, Optiray 300 636 mg/mL may cause temporary discomfort at the injection site, such as warmth or flushing. Some individuals might experience mild side effects like nausea or a metallic taste in the mouth. These effects are generally short-lived and subside quickly. Severe reactions are rare but can occur, and immediate medical attention should be sought if any unusual symptoms arise.

Optiray 300 636 mg/mL should be used with caution in individuals with a history of allergic reactions to contrast agents. It is important to inform healthcare providers about any existing medical conditions, allergies, or medications being taken. Proper hydration before and after the procedure is often recommended to help flush the contrast agent from the body. Always follow the guidance of a healthcare professional for safe administration.

Optiray 300 636 mg/mL may interact with certain medications, particularly those that affect kidney function. It is advisable to discuss all current medications with a healthcare provider before undergoing any procedure involving this contrast agent. Additionally, individuals with pre-existing kidney conditions should be monitored closely, as the contrast agent can potentially impact renal function.